Prm53 - The Use of Proxy Markers to Define Disease Stage in Patients With Malignant Melanoma: An Observational Study Using the Hospital Episode Statistics (Hes) Database in England
Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2175
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV